Skip to content
Search

Latest Stories

Allow pharmacists to alter prescriptions: RPS

The Royal Pharmaceutical Society (RPS) is calling for community pharmacists to be allowed the powers to make changes to prescriptions so they can speed up patients’ access to medicine.

In a letter in The Times ‘Letters to the Editor’ section published today (Aug 6), Sandra Gidley, the RPS president, said the law should be changed so all community phramcists can make changes to prescription.


She argued that this would prevent a lot of unnecessary delays, especially when a medicine was in short supply or out of stock.

“This could be as simple as providing two weeks’ supply and asking the patient to collect the rest in a fortnight. At present any changes to quantities, strength or formulation can legally only be done by the prescriber,” Gidley wrote, noting that only “a change to medicines legislation” can make this happen.

The RPS said the proposed amends would reduce the workload of GPs and give pharmacists more face to face time with patients.

In a statement, RPS Director of Pharmacy Robbie Turner expanded on Gildey's point: “Pharmacists are at the sharp end when patients can’t get the medicines they need. We experienced plenty of difficulties supplying medicines during Covid-19 and in the run up to Brexit and need more flexibility under the law to make simple changes to prescriptions that help patients.

“At present if a patient arrives with a prescription for one pack of 400mg strength tablets which is out of stock, we’re not allowed to alter the prescription so we can provide them with two packets of the 200mg version, which are in stock. Neither are we allowed to change the formulation, so if they’re prescribed capsules which are unavailable, we can’t provide them with tablets or a liquid version of the same medicine.

“Instead, we have to tell the patient they can’t have what’s been prescribed and will face delays in receiving their medicine. We then have to contact other pharmacies to see if they have any stock they can send us, ask the manufacturer for help or call up the patient’s GP and arrange for an alternative to be prescribed.

“This is a waste of everyone’s time when the answer is already sitting there on the shelf. At a time when primary care services are under enormous pressure, it’s right to address this imbalance. The law should be changed so when there are supply problems pharmacists can use their professional judgement to make simple, specific changes to prescriptions for the benefit of all.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less